Groningen

• ​​A Phase 1, Open-Label, Multiple-Part Trial to Evaluate the Drug-Drug Interaction Potential of PRAX-628 in Healthy Participants​ Ended
  2024-514426-23-01 3 2024-08-28 Epilepsy
• A study in healthy men to test how BI 1569912 is processed in the body Ended
  2023-510464-12-00 3 2024-08-26 Healthy volunteer trial
• A study to investigate VMX-C001 in healthy volunteers. Ended
  2024-514339-87-00 3 2024-08-14 To restore coagulation in patients taking DOACs who are experiencing
• A Phase 3b, Double-Blind, Multicenter, Randomized, Vehicle-Controlled, Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Modera … Ended
  2023-505433-27-00 5 2024-08-13 Atopic Dermatitis
• A Phase 2 Dose-Finding Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Reduced Ejec … Ended
  2023-508736-62-00 4 2024-08-08 Heart failure (HF) with reduced ejection fraction (HFrEF)
• A Phase 2 Clinical Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Preserved Ejecti … Ended
  2023-508737-13-00 4 2024-08-08 chronic heart failure
• A Phase I, open-label, fixed sequence drug interaction study in healthy subjects to investigate the effect of a 40 mg deucrictibant tablet a … Ended
  2024-514713-35-00 3 2024-08-08 Hereditary angioedema
• A study to learn how zilucoplan moves throughout the body over time when given in 2 different ways in healthy adults Ended
  2023-508388-64-00 2 2024-08-05 Healthy Volunteers
• A Phase I, open-label, non-randomized study to evaluate the absorption, distribution, metabolism and excretion and pharmacokinetics of DLX31 … Ended
  2023-507959-29-00 3 2024-07-19 Parkinson’s Disease
• A Study in Healthy Adult Male Participants to Evaluate the Metabolism of [14C]PF-06821497 Ended
  2023-508371-36-00 3 2024-07-15 small cell lung cancer (SCLC), castration resistant prostate cancer (C
• A single-dose, open-label study of TX000045 in patients with CpcPH or IpcPH and HFpEF. Ended
  2023-508969-32-00 3 2024-07-08 Combined postcapillary and precapillary pulmonary hypertension / Isola
• Open-label Extension of Vericiguat in Pediatric Participants with Heart Failure due to Left Ventricular Systolic Dysfunction Ended
  2023-506210-40-00 5 2024-06-28 Heart Failure due to Systemic Left Ventricular Systolic Dysfunction
• A Randomised, Placebo-Controlled, Double-blind, Single and Multiple Ascending Dose, Phase 1 Study to Evaluate the Safety, Tolerability, and … Ended
  2023-503917-31-00 1 2024-06-24 Inflammatory disease
• A phase 1 study to assess the mass balance, pharmacokinetics, metabolism, and excretion of GSBR-1290, containing a microtracer dose of [14C] … Ended
  2024-512578-83-00 3 2024-06-24 Not applicable - Healthy volonteers
• A randomized, placebo-controlled, double blind, multiple ascending dose, phase 1 study to evaluate the safety, tolerability, and pharmacokin … Ended
  2024-513127-16-00 3 2024-06-24 NA - healthy volunteers
• A Phase 1/2, adaptive, open-label, single ascending dose to multiple ascending dose study to evaluate the safety, tolerability, pharmacokine … Ended
  2022-502963-39-00 7 2024-06-20 Glycogen storage disease type 1a (GSD1a)
• A Phase 1, Randomized, Open Label, Single-Dose Crossover Study to Assess the Relative Bioavailability, Food Effect, and Safety of Capsule Fo … Ended
  2024-510915-31-00 3 2024-06-14 Not applicable, healthy volunteers
• A Randomized, Double-blind, Controlled, Parallel-group, Single Dose, Three arm Study to Compare the Pharmacokinetic Similarity of MAB-22 Ver … Ended
  2023-509749-11-00 2 2024-06-05 Healthy volunteers
• A phase 3b, interventional, adaptive, clinical trial to evaluate the efficacy and safety of tralokinumab 300 mg every second week monotherap … Ended
  2022-502653-34-01 11 2024-05-30 Atopic dermatitis and moderate-to severe atopic hand eczema
• Safety, pharmacokinetics, and preliminary efficacy of BYON4413 in acute myeloid leukemia and myelodysplastic neoplasms. Ended
  2023-507781-13-00 1 2024-05-24 Patients with relapsed/refractory acute myeloid leukemia or myelodyspl
• A study to compare the pharmacokinetics of salbutamol administered via metered dose inhalers containing propellants HFA-152a (test) or HFA-1 … Ended
  2023-508279-36-00 3 2024-05-22 Healthy volunteers
• A Phase 3, Randomized, Crossover, Open-Label, Active-Controlled Study of Sepiapterin versus Sapropterin in Participants With Phenylketonuria … Ended
  2023-506238-61-00 5 2024-05-10 Phenylketonuria
• A Study to find out the safety, tolerability and interaction of drug with body (including the effect of Itraconazole on RO7268489) and also … Ended
  2024-510606-85-00 3 2024-05-10 Not applicable
• A SINGLE-CENTER, OPEN-LABEL, TWO-PERIOD STUDY TO INVESTIGATE THE EFFECT OF MULTIPLE DOSE ITRACONAZOLE, A STRONG CYP3A INHIBITOR, ON THE PHAR … Ended
  2024-510732-52-00 3 2024-05-07 Not applicable, healthy volunteers

Showing 529–552 of 679 trials